ClinicalTrials.govpublic full text
Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma
multiple myeloma, antibody drug conjugate, belantamab mafodotin, blenrep, dreamm14, gsk2857916, alternative dosing, relapsed or refractory multiple myeloma, rrmm, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 856323
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.